Cardiometabolic & Lipid Disorders
Hypercholesterolemia
Hypercholesterolemia affects millions of individuals worldwide and is a major contributor to cardiovascular disease risk. CenExel partners with sponsors to advance innovative lipid-lowering therapies through expert clinical research, experienced investigators, and access to diverse patient populations.
Studies Conducted
0
+
Trial Participants
0
+
Active Sites
0
+
Overview
Advancing Hypercholesterolemia Clinical Research
CenExel supports clinical trials focused on hypercholesterolemia and related lipid disorders through scientific expertise, operational excellence, and specialized recruitment capabilities. Our experienced research teams help sponsors accelerate study timelines while maintaining the highest standards of patient care and data quality.
Conditions Covered
Hypercholesterolemia Conditions We Research
Our research sites support a broad range of lipid and cardiovascular-related conditions.
- Familial Hypercholesterolemia
- Mixed Dyslipidemia
- Elevated LDL Cholesterol
- Hypertriglyceridemia
- Statin Intolerance
- Cardiovascular Risk Reduction
- Atherosclerosis
- Metabolic Syndrome
Our Approach
Why Sponsors Choose CenExel for Hypercholesterolemia
Our dedicated cardiometabolic research teams provide scientific leadership, advanced recruitment capabilities, and operational efficiency to support successful study execution.
01
Lipid Disorder Expertise
Experienced investigators specializing in cholesterol and cardiovascular-related studies.
02
Diverse Patient Recruitment
Access to broad and diverse patient populations across multiple research sites.
03
Biomarker & Endpoint Strategy
Support for lipid biomarkers, cardiovascular endpoints, and metabolic assessments.
04
Proven Study Performance
Strong enrollment performance and high-quality data delivery across cardiometabolic trials.
Phase Coverage
Supported Trial Phases
CenExel supports early and late-phase hypercholesterolemia studies from first-in-human trials through Phase IV post-marketing research.
Active across all phases
- Phase I
- Phase II
- Phase III
- Phase IV
Our psychiatry research network supports biomarker strategies, decentralized trial components, and patient-focused study execution for anxiety-related indications.
Cardiometabolic Task Force
CenExel supports a broad range of cardiometabolic studies, including hypercholesterolemia, obesity, diabetes, metabolic syndrome, and cardiovascular risk reduction research.
Active Sites
18 Sites
CenExel Phoenix
CenExel Anaheim
CenExel Atlanta
CenExel Marlton
CenExel Gaithersburg
